DC
Dinesh Chander Notiyal
About Dinesh Chander Notiyal
Data last updated:
Dinesh Chander Notiyal has 3 years in corporate governance. Holds Director role. Currently with 2 companies, including Bacil Pharma Ltd and Newtrac Foods & Beverages Limited. Formerly with 2 companies, such as Gb Logistics Commerce Limited and Saketh Sevvenstar Industries Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Bacil Pharma Ltd L24200MH1987PLC043427 | Director | 28 Aug 2024 | 1987 | Active |
 Newtrac Foods & Beverages Limited L46692MH1985PLC037652 | Director | 04 Nov 2023 | 1985 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Gb Logistics Commerce Limited L63030MH2019PLC334896 | Director | 01 Dec 2023 | 2019 | Active |
| Saketh Sevvenstar Industries Limited U84220MH2019PLC331404 | Director | 23 Aug 2023 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dinesh Chander Notiyal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dinesh Chander Notiyal
Dinesh Chander Notiyal has 3 years in corporate governance. Holds Director role. Currently with 2 companies, including Bacil Pharma Ltd and Newtrac Foods & Beverages Limited. Formerly with 2 companies, such as Gb Logistics Commerce Limited and Saketh Sevvenstar Industries Limited. Engaged in General Business. Contributes to corporate operations.
Dinesh Chander Notiyal is associated with 2 companies as Director.
Dinesh Chander Notiyal has expertise in General Business.
Dinesh Chander Notiyal has 3 years in corporate governance.